2024 Q2 Form 10-K Financial Statement

#000149315224014702 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $415.1K
YoY Change -77.39%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$444.7K -$2.389M
YoY Change -57.26% -35.31%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.586M -$3.275M
YoY Change -3431.63% 30.43%
Pretax Income -$5.650M
YoY Change -9.05%
Income Tax
% Of Pretax Income
Net Earnings -$2.031M -$5.650M
YoY Change 104.57% -9.05%
Net Earnings / Revenue -1361.2%
Basic Earnings Per Share -$0.02 -$0.06
Diluted Earnings Per Share -$0.02 -$0.06
COMMON SHARES
Basic Shares Outstanding 117.5M shares 108.8M shares 99.02M shares
Diluted Shares Outstanding 118.2M shares 99.02M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.307K $3.076K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $9.696K $9.696K
Receivables $45.00K $115.1K
Other Receivables
Total Short-Term Assets $56.00K $127.9K
YoY Change -92.12% -87.53%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.554M
YoY Change 161.25%
TOTAL ASSETS
Total Short-Term Assets $56.00K $127.9K
Total Long-Term Assets $1.554M
Total Assets $56.00K $1.682M
YoY Change -98.43% 3.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.943M $2.581M
YoY Change 170.86% 62.54%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.943M $2.581M
Total Long-Term Liabilities
Total Liabilities $2.943M $2.581M
YoY Change 170.86% 62.54%
SHAREHOLDERS EQUITY
Retained Earnings -$49.65M -$47.08M
YoY Change 16.12% 13.64%
Common Stock $46.92M $46.34M
YoY Change 3.43% 9.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.726M -$737.4K
YoY Change
Total Liabilities & Shareholders Equity $56.00K $1.682M
YoY Change -98.43% 3.82%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$2.031M -$5.650M
YoY Change 104.57% -9.05%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.023M
YoY Change -16.33%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $991.2K
YoY Change 43.51%
NET CHANGE
Cash From Operating Activities -$1.023M
Cash From Investing Activities
Cash From Financing Activities $991.2K
Net Change In Cash -$31.87K
YoY Change -94.01%
FREE CASH FLOW
Cash From Operating Activities -$1.023M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
CY2023Q4 us-gaap Investments
Investments
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
usd
CY2022 MWRK Loss On Indirect Write Off Note Receivable
LossOnIndirectWriteOffNoteReceivable
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 MWRK Shares Issued For Services Related Party Consulting Related Party
SharesIssuedForServicesRelatedPartyConsultingRelatedParty
usd
CY2022 MWRK Shares Issued As Compensation Related Parties
SharesIssuedAsCompensationRelatedParties
usd
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022 MWRK Loss On Indirect Write Off Note Receivables
LossOnIndirectWriteOffNoteReceivables
usd
CY2023 MWRK Change In Fair Value Of Investment
ChangeInFairValueOfInvestment
usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2023 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023 MWRK Proceeds From Issuance Of Enderbyworks Shares To Minority Shareholders
ProceedsFromIssuanceOfEnderbyworksSharesToMinorityShareholders
usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
usd
CY2023Q4 MWRK Investments Related Party Noncurrent
InvestmentsRelatedPartyNoncurrent
usd
CY2023 MWRK Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
pure
CY2022 MWRK Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
pure
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 MWRK Income Tax Reconciliation Change In Derivatives
IncomeTaxReconciliationChangeInDerivatives
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
usd
CY2022 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Security12g Title
Security12gTitle
Common Stock
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
5249764.38 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
117452923 shares
CY2023 dei Auditor Firm
AuditorFirmId
6624
CY2023 dei Auditor Name
AuditorName
INTEGRITAT CPA
CY2023 dei Auditor Location
AuditorLocation
Boca Raton, Florida
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3076 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34941 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
115112 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
167213 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9696 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24896 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
127884 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1025232 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1554250 usd
CY2022Q4 us-gaap Investments
Investments
627 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1554250 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
594938 usd
CY2023Q4 us-gaap Assets
Assets
1682134 usd
CY2022Q4 us-gaap Assets
Assets
1620170 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
77700 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
77700 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
271247 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
215465 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2580767 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1587773 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2580767 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1587773 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
108807923 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
108807923 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78145066 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78145066 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
108808 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
78145 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
46232087 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
42264139 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47078270 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41428167 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-737375 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
914117 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-161258 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-881720 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-898633 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32397 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1682134 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1620170 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
415082 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1835773 usd
CY2023 MWRK Service Costs
ServiceCosts
439648 usd
CY2022 MWRK Service Costs
ServiceCosts
1239077 usd
CY2023 MWRK Operating Income Expenses
OperatingIncomeExpenses
-2804222 usd
CY2022 MWRK Operating Income Expenses
OperatingIncomeExpenses
-5528831 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-2389140 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-3693058 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7287 usd
CY2023 MWRK Note Interest Revenue
NoteInterestRevenue
397592 usd
CY2022 MWRK Note Interest Revenue
NoteInterestRevenue
117721 usd
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
253473 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
6601 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
440065 usd
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2625000 usd
CY2023 MWRK Loss On Indirect Write Off Note Receivable
LossOnIndirectWriteOffNoteReceivable
3418584 usd
CY2023 MWRK Income Loss From Investments Write Off
IncomeLossFromInvestmentsWriteOff
-673 usd
CY2022 MWRK Income Loss From Investments Write Off
IncomeLossFromInvestmentsWriteOff
-430005 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3275138 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2511107 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-5664278 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-6204165 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14175 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8122 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-5650103 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-6212287 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99019277 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99019277 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77468853 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77468853 shares
CY2023 us-gaap Profit Loss
ProfitLoss
-5664278 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-6204165 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
183159 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
-31977 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
494679 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1887737 usd
CY2023 MWRK Shares Issued For Services Consulting
SharesIssuedForServicesConsulting
404000 usd
CY2022 MWRK Shares Issued For Services Consulting
SharesIssuedForServicesConsulting
29997 usd
CY2023 MWRK Shares Issued For Services Related Party Consulting Related Party
SharesIssuedForServicesRelatedPartyConsultingRelatedParty
11250 usd
CY2023 MWRK Shares Issued As Compensation Related Parties
SharesIssuedAsCompensationRelatedParties
11250 usd
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2625000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
195688 usd
CY2023 MWRK Loss On Indirect Write Off Note Receivables
LossOnIndirectWriteOffNoteReceivables
-3418584 usd
CY2022 MWRK Change In Fair Value Of Investment
ChangeInFairValueOfInvestment
-32648 usd
CY2023 MWRK Interest Income
InterestIncome
81499 usd
CY2022 MWRK Interest Income
InterestIncome
117720 usd
CY2023 MWRK Loss From Investments Write Off
LossFromInvestmentsWriteOff
627 usd
CY2022 MWRK Loss From Investments Write Off
LossFromInvestmentsWriteOff
430005 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
440065 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
143587 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
167213 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-15200 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-80895 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-385061 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
223536 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
516941 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
43557 usd
CY2022 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
7292 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
77700 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1023047 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1222773 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
515891 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
221250 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
460109 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
13077 usd
CY2022 MWRK Proceeds From Issuance Of Enderbyworks Shares To Minority Shareholders
ProceedsFromIssuanceOfEnderbyworksSharesToMinorityShareholders
4900 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
25000 usd
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
910400 usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
477611 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
991182 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
690684 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31865 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-532089 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34941 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
567030 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
48238 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2521 usd
CY2023 us-gaap Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
2018517 usd
CY2023 MWRK Allocation Of Net Loss To Noncontrolling Interest
AllocationOfNetLossToNoncontrollingInterest
-14175 usd
CY2022 MWRK Allocation Of Net Loss To Noncontrolling Interest
AllocationOfNetLossToNoncontrollingInterest
8122 usd
CY2023 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
1554250 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3611375 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-31977 usd
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1855233 usd
CY2022 MWRK Stock Issued During Period Value Prior Period Adjustment To Correct Error In Share Based Compensation
StockIssuedDuringPeriodValuePriorPeriodAdjustmentToCorrectErrorInShareBasedCompensation
32504 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
444111 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
29997 usd
CY2022 MWRK Stock Issued During Period Value Noncontrolling Interest
StockIssuedDuringPeriodValueNoncontrollingInterest
4900 usd
CY2022 MWRK Stock Issued During Period Stock Warrants Expiry
StockIssuedDuringPeriodStockWarrantsExpiry
34530 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
222389 usd
CY2022 MWRK Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
33500 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-6204165 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32397 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32397 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
183153 usd
CY2023 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
494679 usd
CY2023 MWRK Stock Issued During Period Value Issued For Software Development Services
StockIssuedDuringPeriodValueIssuedForSoftwareDevelopmentServices
700000 usd
CY2023 MWRK Stock Granted During Period Value Sharebased Compensation To Related Party
StockGrantedDuringPeriodValueSharebasedCompensationToRelatedParty
11250 usd
CY2023 MWRK Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
910399 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
404000 usd
CY2023 MWRK Stock Issued During Period Value Issued For Services Related Party
StockIssuedDuringPeriodValueIssuedForServicesRelatedParty
11250 usd
CY2023 MWRK Adjustment To Additional Paid In Capital Acquisition Of Noncontrolling Interest
AdjustmentToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest
2018517 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-5664278 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-898633 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-898633 usd
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2010-07-20
CY2010Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2010Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47078270 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41428167 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-5664278 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-6204165 usd
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z5AN83oOYAG" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zO49a5fUAAJ3">Reclassification</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to prior periods to conform with current reporting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zMwLdwWEtSC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zR04UIA1ohea">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates and these differences could be material.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The most significant estimates made by management in the preparation of the financial statements relate to the estimates used to calculate the fair value of certain liabilities, the derivative liability, present value of note payable and note receivable, the valuation of investments and any impairment and the net book value of long-lived assets. Management bases its estimates on historical experience and on other various assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from such estimates under different assumptions and conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
195688 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
7000000 shares
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
415082 usd
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q4 us-gaap Cash
Cash
0 usd
CY2022Q4 us-gaap Cash
Cash
0 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
115112 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
167213 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9696 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24896 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9696 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24896 usd
CY2023Q4 us-gaap Retainage Deposit
RetainageDeposit
9696 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
7000000 shares
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1554250 usd
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.10
CY2022Q4 MWRK Investments Related Party Noncurrent
InvestmentsRelatedPartyNoncurrent
627 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
77700 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
77700 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
77700 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
19807614 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
18102771 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
10128571 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
3813593 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
19656521 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
2108750 shares
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
10279664 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
19807614 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.5569
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.6033
CY2022Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
488281 shares
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.2048
CY2022Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
100000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
244111 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1000000 shares
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.10
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
100000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
725000 shares
CY2023Q2 us-gaap Share Price
SharePrice
0.05
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
36250 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
3720000 shares
CY2023Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
279000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7000000 shares
CY2023Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
700000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
160714 shares
CY2023Q3 us-gaap Share Price
SharePrice
0.07
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
11250 usd
CY2023Q4 us-gaap Share Price
SharePrice
0.09
CY2022Q4 us-gaap Share Price
SharePrice
0.09
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.09
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.09
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.033 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0304 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.864 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8992 pure
CY2023 MWRK Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Dividend Per Share
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsDividendPerShare
0.00
CY2022 MWRK Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Dividend Per Share
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsDividendPerShare
0.00
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4214489 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3897793 usd
CY2023 MWRK Carry Forwards Expire
CarryForwardsExpire
expire through the year 2043
CY2023 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The Tax Cuts and Jobs Act was enacted on December 22, 2017, which reduced the U.S. corporate statutory tax rate from 35% to 21% beginning on January 1, 2018. We used 21% as an effective rate.
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5650103 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6212287 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1186522 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1304580 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
142345 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
389710 usd
CY2022 MWRK Income Tax Reconciliation Change In Derivatives
IncomeTaxReconciliationChangeInDerivatives
-92414 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1044177 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1007284 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4941970 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3897793 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4941970 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3897793 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4941970 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3897793 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-881720 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-894742 usd
CY2022 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
4900 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14175 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8122 usd
CY2023 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
734637 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-161258 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-881720 usd

Files In Submission

Name View Source Status
0001493152-24-014702-index-headers.html Edgar Link pending
0001493152-24-014702-index.html Edgar Link pending
0001493152-24-014702.txt Edgar Link pending
0001493152-24-014702-xbrl.zip Edgar Link pending
ex10-106.htm Edgar Link pending
ex10-107.htm Edgar Link pending
ex10-108.htm Edgar Link pending
ex10-109.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-1_001.jpg Edgar Link pending
ex23-2.htm Edgar Link pending
ex23-2_001.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
mwrk-20231231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
mwrk-20231231_cal.xml Edgar Link unprocessable
mwrk-20231231_def.xml Edgar Link unprocessable
mwrk-20231231_lab.xml Edgar Link unprocessable
mwrk-20231231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable